Oslo, Norway, 5 May 2025: Photocure ASA (OSE: PHO), held its annual general
meeting on 5 May 2025 at 17:00 hours (CEST).
The minutes from the general meeting setting out the resolutions are attached
hereto.
For further information, please contact:
Photocure
CFO Erik Dahl
Tel: + 47 450 55000
Email: ed@photocure.no
About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative solutions to
improve the lives of bladder cancer patients. Our unique technology, which makes
cancer cells glow bright pink, has led to better health outcomes for patients
worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo
Stock Exchange (OSE: PHO). For more information, please visit us at
www.photocure.com and www.cysview.com.
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.